Atherosclerosis is epidemiologically linked and causally related to the presence of 'risk factors'. Despite their diversity, major risk factors for cardiovascular disease such as hypercholesterolaemia, diabetes, hypertension, physical inactivity, obesity, and tobacco smoking share a common 'systemic' mechanism of action, i.e. they act on the entire inner surface of the arterial vascular tree. The cellular and molecular effects of such systemic risk factors, acting through biohumoral mediators, can account for the greater or lesser propensity of different individuals to atherosclerotic vascular disease (the 'biohumoral' paradigm). 1, 2 Atherosclerosis is, however, focal and discrete in location and has clear preferences for certain sites of the vasculature, such as branching points, bifurcations, or the convex side of curved arteries. In addition, some arteries are more prone to atherosclerosis than others (e.g. the carotid artery vs. the subclavian artery, epicardial coronary arteries vs. intramyocardial arteries), and there are preferential locations even within extremely close areas in the same artery, such as in the region of the carotid bifurcation. The 'site-specific' location of the process is a golden opportunity, and perhaps a 'Holy Grail' for atherosclerosis research. It is usually explained by the action of particular types of shear stress imposed on the arterial wall by flow regimens of the circulating blood. 3 In recent years, much progress has been gained in understanding how shear stress is transduced within the artery wall in order to protect from or promote atherogenesis (the 'biomechanical' paradigm). Crucial to this understanding is the identification of endothelial responses to shear stress, by which endothelial cells can sense and integrate haemodynamic stimuli and react to them.
The arterial endothelium is exposed to three main varieties of haemodynamic forces:
4,5 (a) the pressure generated by hydrostatic forces towards the vessel wall; (b) circumferential tensions or stress, resulting from traction forces exerted by intercellular connections during vasomotion; (c) shear stress, i.e. biomechanical dragging frictional forces created by the flowing blood on the arterial wall.
Shear stress is the best candidate to explain the discrete and focal nature of atherosclerosis. Conway et al. 6 points out that cytochromes CYP1A1 and CYP1B1 are directly affected by different durations, levels, and patterns of shear stress. To put these novel findings in perspective, we will here briefly outline the current knowledge on the effects of biomechanical forces on the vascular endothelium.
Shear stress is determined by three physical components: blood flow, blood viscosity, and vessel geometry. They are measured through the applications of fluid dynamics principles, and are expressed in dynes per square centimetre. By acting directly on the endothelium, shear stress profoundly affects endothelial function and, as a consequence, the entire physiology of the vessel wall.
In linear segments of the arteries, blood flows laminarly, with a pulsatility dependent on the cardiac cycle. In such segments, endothelial cells are submitted to relatively high shear stress with an average high and relatively uniform-spatial and temporal-intensity. Such conditions promote the organization of endothelial cytoskeleton, orienting the longitudinal axis of cells parallel to the direction of flow. 7, 8 In such conditions, a true 'optimization' of the cellular functional status occurs, through a maximal expression-compared with static culture conditions-of antioxidant systems such as manganese superoxide dismutase (SOD) 9 , of antithrombotic and vasodilatory substances such as nitric oxide (NO), prostacyclin (PGI 2 ), 9 thrombomodulin, and plasminogen activator inhibitor-1, 10 and the suppression of specific prothrombotic substances such as tissue factor and vasoconstrictors such as endothelin-1 (ET-1). 11 Conversely, athero-prone areas are regions of flow separation, recirculation, reattachment, and-perhaps most importantly-significant temporal and spatial gradients of shear stress. 12, 13 In such regions, the normally unidirectional and high shear stress is suddenly broken, with the end result being dynamically complex, oscillating and low shear stress. As an example, in the carotid artery bifurcation, the medial wall of the carotid bulb (which is the more athero-protected area) continues to have high shear stress, in the order of 10-30 dyne/cm 2 ; on the contrary, in the flow divider and the lateral wall there are complex and low-intensity shear stresses (,5 dyne/cm 2 ) characterized by inversions of the flow direction according to the cardiac cycle (recirculating vortexes). 13 In such haemodynamic conditions, cells are not stimulated to orient themselves in the direction of the flow and feature a profound functional derangement favouring the development of atheromatous lesions ( Figure 1 ).
There is no universal agreement as to the type of endothelial receptors able to 'sense' the variations in haemodynamic flow and to orchestrate a pro-or anti-atherogenic response. Regulation of membrane potential is one possible way by which endothelial cells sense shear stress. Many of the enzymes governing the production of pro-and anti-atherogenic substances are sensitive to-and activated by-changes in membrane potentials. They are activated by the entry of Ca 2þ and the subsequent increase in cytosolic Ca 2þ levels. In particular,
laminar shear stress appears to stimulate calcium-dependent potassium channels at intermediate conductance (IK Ca1 ). This would be followed by membrane hyperpolarization, an increase in Ca 2þ entry, and the ensuing stimulation of calciumsensitive atheroprotective proteins, 4,14 a paradigm for this being the expression of endothelial nitric oxide synthase (eNOS).
14 Many of the other substances affected by shear stress, however, appear to be regulated differently. Low values of shear stress indeed correlate, besides with a reduction in the production of NO, with increased subendothelial retention of lipoprotein particles, a higher expression of endothelial leucocyte adhesion molecules, such as vascular cell adhesion molecule-1 (VCAM-1, promoting monocyte adhesion), platelet-derived growth factor (PDGF), ET-1, and angiotensin-converting enzyme (ACE), 5, 15, 16 which all would favour the development of lesions. Changes in the levels of these mediators appear mostly as the result of the activation/inhibition of gene expression. It seems therefore that a complex combination of transcriptional and posttranscriptional mechanisms comes into play in providing the endothelial phenotypic changes in response to flow patterns.
Beyond the activation of ion channels, the contribution of integrins, extracellular matrix, caveolae, and G proteincoupled receptors has been postulated. Integrins are transmembrane glycoproteins involved in the adhesion of cells to the extracellular matrix. Their involvement in the transduction of changes of haemodynamic forces into biochemical intracellular signals has been demonstrated with the use of physical techniques such as magnetic torsion. 17, 18 In addition, the blockage/interference of integrin receptors with Arg-GlyAsp-containing synthetic peptides or with anti-integrin antibodies blocks NO-mediated vasodilation in response to flow. 19 Caveolae, which are cholesterol-rich specialized plasma membrane microdomains, are a third possible candidate for the function of mechano-sensors. Because of their high cholesterol content, they are more rigid than other regions of the plasma membrane and, therefore, potentially more sensitive than neighbouring regions to changes in flow conditions and in the cytoskeletal organization. The main component of caveolae is an integral membrane protein called caveolin, which seems to work as a bridge for the recruitment and sequestration of an entire array of signalling molecules, including G proteins, some tyrosine kinases, and eNOS. 20 G proteins have also been indicated as a fourth possible mechano-sensor in endothelial cells. G proteins (termed as such because they bind guanosine trisphosphate, GTP) are trimeric GTPases consisting of three different protein subunits, a, b, and g. These proteins are coupled with membrane receptors belonging to the class of 'seven transmembrane domain' or 'serpentine' receptors-spanning the plasma membrane seven times-such as the cholinergic muscarinic receptor, the adrenergic and dopaminergic receptors, the receptors for serotonin, cannabinoids, opiates, and purines. It seems probable that haemodynamic stimuli can also activate G-proteins, since the blockade-both pharmacological and biological-of G-proteins inhibits shear stress-induced activation of some signalling molecules, such as extracellular regulated kinase (ERK) 1/2. 21 There is no consensus about the functional prevalence of one mechano-sensor over others. Rather, most scientists believe that each serves an active role and is able to cooperate with others to produce an integrated endothelial response.
Intracellular effects of shear stress, after stimulation of the appropriate mechano-sensors, appear to be mediated by signalling pathways, among which the mitogen-activated protein kinases are the best studied. Some data in the literature report on fluid-mediated activation both of ERK1/2 and of c-Jun N-terminal kinases (JNKs), according to exposure times and intensity, but independent of intracellular Ca 2þ levels 5 . By some, still unknown, mechanisms, variations in shear stress eventually translate into variations in the expression of genes through the activation of promoter sequences termed 'shear stress-responsive elements' (SSREs), present in a variety of genes whose products affect atherosclerosis and inflammation. 12 With the purpose of characterizing the endothelial gene repertoire regulated by variations in shear stress, several research groups have used gene-profiling techniques through DNA microarray platforms. With such approaches, transcription factors Kruppel-like factor (KLF)-2 11, 22, 23 and NF-E2-related factor (Nrf)2 24 have been identified as transcription factors playing a prominent role in these alterations in endothelial cells. KLF-2, which is tonically activated in conditions of laminar shear stress and, conversely, inhibited in athero-prone regions, 25 would act, at least in part, by sequestering the main co-activators of the other 'general' pro-atherogenic/pro-inflammatory transcription factor nuclear (NF)-kB. Probably in this way, KLF-2 prevents the expression of pro-atherogenic, pro-inflammatory genes, such as those for VCAM-1 and Eselectin. In addition, KLF-2 augments the expression of thrombomodulin and eNOS and suppresses the expression of plasminogen activator inhibitor-1 (PAI-1) and of tissue factor (TF), thus contributing overall to the maintenance of an anti-inflammatory, anti-thrombotic profile of the vascular endothelium. Therefore, KLF-2 appears to act as one general atheroprotective coordinating factor. Nrf2 has been mostly linked to effects on redox-related gene homeostasis, and is also able, by this very broad mechanism, to control the downstream activation of several other genes. 24 Both CYP1A1 and CYP1B1 are two of the three reported cytochrome P450 genes (out of a total of 57 human P450 isoforms) 26 directly affected by shear stress. Conway et al. 6 report on the effects of different durations, levels, and patterns of shear stress on the activation of CYP1A1 and CYP1B1. 6 Here mRNA, protein, and enzyme activities of these cytochromes were maximally increased at 24 h of arterial levels of shear stress (15-25 dyne/cm 2 ). Reversing shear stress significantly attenuated the expression of both genes. Small interfering RNA knockdown of CYP1A1 resulted in significantly reduced CYP1B1 (showing the inter-dependence of these two genes) and the downstream expression of the 'atheroprotective' thrombospondin-1 gene. Immunostaining of human coronary arteries showed constitutive CYP1A1 and CYP1B1 protein expression in endothelial cells, and immunostaining of mouse aortas showed increased expression of CYP1A1 in the descending thoracic aorta (an athero-protected area), whereas attenuated CYP1A1 expression was observed in the lesser curvature of the aortic arch, an athero-prone region. 6 Thus, CYP1A1 and CYP1B1 gene and protein expression varies with time, magnitude, and pattern of shear stress, and the increased expression of both genes appears to reflect an antiatherogenic endothelial cell phenotype.
This study confirms, but also significantly extends, the previous observations by other groups 25, 27, 28 and makes CYP1A1 and CYP1B1 genes candidates for the role of important regulators of endothelial responses to haemodynamic forces. Other shear stress-responsive genes (KLF-2, eNOS, and ET-1) were measured following CYP1A1 or CYP1B1 siRNA treatment, but no significant differences in the expression of such genes were found, suggesting that both CYP1A1 and CYP1B1 affect endothelial cells differently from other regulators investigated previously. As the authors correctly point out, the gene-signalling capacities of CYP1A1 and CYP1B1 activation by shear stress need additional investigation, in particular by focusing on the identity of substrates for these two genes. The ability of cytochrome P450s to produce signalling and vasoreactive molecules from fatty acids, such as epoxyeicosatrienoic acids, and steroids has long been recognized in cardiovascular research. Epoxyeicosatrienoic acids are a group of P450 metabolites that are increased following shear stress 29, 30 and might be the products of these CYP1A1 and CYP1B1 shear stress-regulated genes. Metabolites of these cytochromes may have vasodilating properties and act as endothelium-derived hyperpolarizing factors. [31] [32] [33] Such compounds have the potential of altering endothelial physiology and mediate the anti-atherogenic phenotype associated with the enhanced expression of such genes, but such possibilities will have to be verified by future research. In the meantime, the current data suggest that another piece in the puzzle of our understanding of the biomechanical paradigm of atherosclerosis has been put in place. This is an important line of research, and not only because of our advancement in knowledge. Indeed, this might ultimately lead to the development of novel anti-atherogenic therapies through pharmacology or molecular biology strategies, mimicking the action of nature in steady, unperturbed areas of laminar blood flow.
